Berberine Ursodeoxycholate

熊去氧胆小檗碱

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameBerberine Ursodeoxycholate
Drug Alias Name小檗碱熊去氧胆酸盐Ursodeoxycholic acid berberineHTD-1801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid modulators
TargetsLipid
Therapy Area/IndicationsHypercholesterolemiaDiabetes Mellitus, Type 2Renal Insufficiency, Chronic +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[6] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShenzhen Haipurui Automation Equipment Co LtdShenzhen Hightide Biopharmaceutical Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHightide Biopharma Pty LtdShenzhen Hightide Biopharmaceutical LtdInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Renal Insufficiency, ChronicMetabolic Dysfunction-Associated Steatotic Liver Disease +[9] 
Inactive IndicationsHypercholesterolemiaDigestive System Diseases

Other Information

ATC CodeN/A
Related LinksN/A